Literature DB >> 29538639

Demonstration of Near-Elimination of Hepatitis C Virus Among a Prison Population: The Lotus Glen Correctional Centre Hepatitis C Treatment Project.

Sofia R Bartlett1, Penny Fox2, Harris Cabatingan3, Anissa Jaros3, Carla Gorton4, Rhondda Lewis4, Eugene Priscott4, Gregory J Dore1, Darren B Russell4,5,6.   

Abstract

Micro-elimination of hepatitis C virus (HCV) infection through rapid uptake of government-funded direct-acting antiviral therapy within an Australian prison setting is demonstrated. During a 22-month period, 119 patients initiated treatment for chronic HCV infection, with HCV in-prison viremic prevalence declining from 12% to 1%.

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29538639     DOI： 10.1093/cid/ciy210

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  13 in total

Review 1.  Prisons: ignore them at our peril.

Authors:  Adeeba Kamarulzaman; Annette Verster; Frederick L Altice
Journal:  Curr Opin HIV AIDS       Date:  2019-09       Impact factor: 4.283

Review 2.  Hepatitis C virus (HCV) care in Canadian correctional facilities: Where are we and where do we need to be?

Authors:  Nadine Kronfli; Jane A Buxton; Lindsay Jennings; Fiona Kouyoumdjian; Alexander Wong
Journal:  Can Liver J       Date:  2019-12-10

3.  Microelimination of Chronic Hepatitis C by Universal Screening Plus Direct-Acting Antivirals for Incarcerated Persons in Taiwan.

Authors:  Tsung-Hua Yang; Yu-Jen Fang; Shih-Jer Hsu; Ji-Yuh Lee; Min-Chin Chiu; Jian-Jyun Yu; Chia-Chi Kuo; Chien-Hung Chen
Journal:  Open Forum Infect Dis       Date:  2020-07-17       Impact factor: 3.835

Review 4.  The Elimination of Hepatitis C as a Public Health Threat.

Authors:  Margaret Hellard; Sophia E Schroeder; Alisa Pedrana; Joseph Doyle; Campbell Aitken
Journal:  Cold Spring Harb Perspect Med       Date:  2020-04-01       Impact factor: 6.915

5.  Universal HIV and Birth Cohort HCV Screening in San Diego Emergency Departments.

Authors:  Martin Hoenigl; Kushagra Mathur; Jill Blumenthal; Jesse Brennan; Miriam Zuazo; Melanie McCauley; Lucy E Horton; Gabriel A Wagner; Sharon L Reed; Gary M Vilke; Christopher J Coyne; Susan J Little
Journal:  Sci Rep       Date:  2019-10-09       Impact factor: 4.379

6.  Prevalence of Viremic hepatitis C, hepatitis B, and HIV infection, and vaccination status among prisoners in Stockholm County.

Authors:  Caroline Gahrton; Gabriel Westman; Karin Lindahl; Fredrik Öhrn; Olav Dalgard; Christer Lidman; Lars-Håkan Nilsson; Karouk Said; Ann-Sofi Duberg; Soo Aleman
Journal:  BMC Infect Dis       Date:  2019-11-09       Impact factor: 3.090

7.  Hepatitis C virus infection in EU/EEA and United Kingdom prisons: opportunities and challenges for action.

Authors:  Aya Olivia Nakitanda; Linda Montanari; Lara Tavoschi; Antons Mozalevskis; Erika Duffell
Journal:  BMC Public Health       Date:  2020-11-09       Impact factor: 3.295

8.  A decentralised, multidisciplinary model of care facilitates treatment of hepatitis C in regional Australia.

Authors:  Andrew Lee; Josh Hanson; Penny Fox; Greg Spice; Darren Russell; Peter Boyd
Journal:  J Virus Erad       Date:  2018-07-01

9.  Competing priorities and second chances - A qualitative exploration of prisoners' journeys through the Hepatitis C continuum of care.

Authors:  Desmond Crowley; Walter Cullen; John S Lambert; Marie Claire Van Hout
Journal:  PLoS One       Date:  2019-09-11       Impact factor: 3.240

10.  Continuum of hepatitis C care cascade in prison and following release in the direct-acting antivirals era.

Authors:  Sanam Hariri; Heidar Sharafi; Mahdi Sheikh; Shahin Merat; Farnaz Hashemi; Fatemeh Azimian; Babak Tamadoni; Rashid Ramazani; Mohammad Mehdi Gouya; Behzad Abbasi; Mehrzad Tashakorian; Ramin Alasvand; Seyed Moayed Alavian; Hossein Poustchi; Reza Malekzadeh
Journal:  Harm Reduct J       Date:  2020-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.